Beckley Psytech's investors want to put more money into the psychedelics company at a $200 million valuation

Psychedelics Policy Newsletter: Reforms for Congress, data for rescheduling, and more

Welcome to Reason Foundation’s newsletter on psychedelics policy. This edition covers: How Congress can promote access to psychedelic medicine New data dashboard and analysis for rescheduling psychedelics The state roundup Legislative approaches that could improve access to psychedelic-based medicine Reason Foundation responded to a request for comment from the Congressional Psychedelics Advancing Therapies Caucus. We recommended that Congress …

Beckley Psytech's investors want to put more money into the psychedelics company at a $200 million valuation

Eugene Mymrin/Getty ImagesA Beckley Psytech investor is looking to invest up to an extra $20 million in the biotech startup.Noetic Fund wants to back Beckley Psytech at a $200 million valuation, per an email seen by BI.The startup is developing a psychedelic-based nasal spray to treat depression.Beckley Psytech's investors are trying to drum up enthusiasm to put fresh funding into the biotech startup, Business Insider has learned, as Beckley adv…